Company Search:
Advanced Search
Sponsored Links
BioLine RX Ltd Company Snapshot
BioLine RX Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares BioLine RX Ltd with three other pharmaceutical manufacturers in Middle East: GlaxoSmithKline SAE of EGYPT (2010 sales of 726.84 million Egyptian Pounds [US$46.15 million] of which 100% was Pharmaceutical Products), Medical Union Pharmaceuticals Company of EGYPT (780.88 million Egyptian Pounds [US$49.58 million] ), and Memphis Pharmaceuticals and Chemical Industries SAE which is also based in EGYPT (620.11 million Egyptian Pounds [US$39.37 million] ).

Sales Analysis.
  Stock Performance Chart for BioLine RX Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2020): .40
(Figures in Israel Shekels)
1 Week 2.0%   13 Weeks -16.9%  
4 Weeks -0.5%   52 Weeks -42.0%  
BioLine RX Ltd Key Data:
  Ticker: BLRX Country: Israel
  Exchanges: TEL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2010 Sales 113,160,000
(Year Ending Jan 2011).
Employees: 52
  Currency: Israel Shekels Market Cap: 118,306,911
  Fiscal Yr Ends: December Shares Outstanding: 296,508,550
  Share Type: Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.